Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katya Zelevinsky

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Community Mental Health Journal|May 18, 2023
Healthcare Access for a Diverse Population with Schizophrenia Following the Onset of the COVID-19 PandemicMarcela Horvitz-Lennon, Emily Leckman-Westin, Molly Finnerty, et al.
Journal of the American College of Cardiology|February 19, 2011
Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty RegistryFrederic S Resnic, Sharon-Lise T Normand, Thomas C Piemonte, et al.
Circulation|October 15, 2008
Long-term clinical outcomes after drug-eluting and bare-metal stenting in MassachusettsLaura Mauri, Treacy S Silbaugh, Robert E Wolf, et al.
Psychiatric Services (Washington, D.C.)|June 12, 2024
Racial-Ethnic Disparities in Quality of Care Among Medicaid Beneficiaries With SchizophreniaSharon-Lise Normand, Katya Zelevinsky, Molly Finnerty, et al.
Statistics in Medicine|February 5, 2024
Targeted learning in observational studies with multi-valued treatments: An evaluation of antipsychotic drug treatment safetyJason Poulos, Marcela Horvitz-Lennon, Katya Zelevinsky, et al.
The New England Journal of Medicine|September 26, 2008
Drug-eluting or bare-metal stents for acute myocardial infarctionLaura Mauri, Treacy S Silbaugh, Pallav Garg, et al.
Circulation|November 13, 2008
Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center RegistryPallav Garg, Sharon-Lise T Normand, Treacy S Silbaugh, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2013
A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary interventionJason H Wasfy, Kenneth Rosenfield, Katya Zelevinsky, et al.
Circulation. Cardiovascular Interventions|March 23, 2012
Sources of hospital variation in short-term readmission rates after percutaneous coronary interventionRobert W Yeh, Kenneth Rosenfield, Katya Zelevinsky, et al.
Circulation. Cardiovascular Interventions|January 16, 2014
Causes of short-term readmission after percutaneous coronary interventionJason H Wasfy, Jordan B Strom, Cashel O'Brien, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Community Mental Health Journal|May 18, 2023
Healthcare Access for a Diverse Population with Schizophrenia Following the Onset of the COVID-19 PandemicMarcela Horvitz-Lennon, Emily Leckman-Westin, Molly Finnerty, et al.
Journal of the American College of Cardiology|February 19, 2011
Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty RegistryFrederic S Resnic, Sharon-Lise T Normand, Thomas C Piemonte, et al.
Circulation|October 15, 2008
Long-term clinical outcomes after drug-eluting and bare-metal stenting in MassachusettsLaura Mauri, Treacy S Silbaugh, Robert E Wolf, et al.
Psychiatric Services (Washington, D.C.)|June 12, 2024
Racial-Ethnic Disparities in Quality of Care Among Medicaid Beneficiaries With SchizophreniaSharon-Lise Normand, Katya Zelevinsky, Molly Finnerty, et al.
Statistics in Medicine|February 5, 2024
Targeted learning in observational studies with multi-valued treatments: An evaluation of antipsychotic drug treatment safetyJason Poulos, Marcela Horvitz-Lennon, Katya Zelevinsky, et al.
The New England Journal of Medicine|September 26, 2008
Drug-eluting or bare-metal stents for acute myocardial infarctionLaura Mauri, Treacy S Silbaugh, Pallav Garg, et al.
Circulation|November 13, 2008
Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center RegistryPallav Garg, Sharon-Lise T Normand, Treacy S Silbaugh, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2013
A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary interventionJason H Wasfy, Kenneth Rosenfield, Katya Zelevinsky, et al.
Circulation. Cardiovascular Interventions|March 23, 2012
Sources of hospital variation in short-term readmission rates after percutaneous coronary interventionRobert W Yeh, Kenneth Rosenfield, Katya Zelevinsky, et al.
Circulation. Cardiovascular Interventions|January 16, 2014
Causes of short-term readmission after percutaneous coronary interventionJason H Wasfy, Jordan B Strom, Cashel O'Brien, et al.
Pageof 4